Tag: CymaBay Therapeutics Inc

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to CymaBay Therapeutics Inc

CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Drops -3.49% in a week: What's Hurting the Stock?

Added to Collection on: 2020-12-05 20:00:03

Tags for this article:

Economy
Finance
Stock market
Financial markets
Financial regulation
Short
Stock
NASDAQ
Share price
Exchange-traded fund
Barron's 400 Index
CymaBay Therapeutics Inc

Click the tags to see associated articles and topics

View Article Details
CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Receives Consensus Rating of "Buy" from Analysts

Added to Collection on: 2020-12-12 06:15:59

Tags for this article:

Finance
Money
Financial markets
Alternative investment management companies
Corporate finance
Stock
Stock market
Short
Hedge fund
CymaBay Therapeutics Inc
NASDAQ COMPOSITE INDEX

Click the tags to see associated articles and topics

View Article Details
Poised For Better Performance? CymaBay Therapeutics Inc. (CBAY) and Navient Corporation (NAVI)

Added to Collection on: 2021-03-03 13:30:00

Tags for this article:

Financial markets
Finance
Stock market
Financial economics
Navient
Corporate finance
Equity securities
Stock
Navi
NASDAQ
COMMODORE CAPITAL LP
CymaBay Therapeutics Inc

Click the tags to see associated articles and topics

View Article Details
CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Expected to Announce Earnings of -$0.20 Per Share

Added to Collection on: 2021-03-06 07:55:05

Tags for this article:

Financial ratios
Finance
Economy
Money
Fundamental analysis
Price?earnings ratio
Earnings per share
ANGI Homeservices
BlackRock
Securities research
CymaBay Therapeutics Inc

Click the tags to see associated articles and topics

View Article Details
CymaBay Appoints Thomas Wiggans and Janet Dorling to Board of Directors

Added to Collection on: 2021-04-05 12:00:00

Tags for this article:

Biotechnology
Life Sciences
Gilead Sciences
Pharmaceutical industry
United Therapeutics
CymaBay Therapeutics Inc
Janet Dorling

Click the tags to see associated articles and topics

View Article Details
CymaBay Names Lewis Stuart Chief Commercial Officer

Added to Collection on: 2021-05-10 12:00:00

Tags for this article:

Life Sciences
Biotechnology
Roivant Sciences
Biopharmaceutical
Prostate cancer
CymaBay Therapeutics Inc
Lewis Stuart

Click the tags to see associated articles and topics

View Article Details
CymaBay Reports First Quarter 2021 Financial Results and Provides Corporate Update

Added to Collection on: 2021-05-13 20:03:45

Tags for this article:

Pharmaceutical industry
Health sciences
Medical specialties
Health
Clinical research
Drug discovery
Clinical trial
Design of experiments
Primary biliary cholangitis
Patient recruitment
CymaBay Therapeutics Inc

Click the tags to see associated articles and topics

View Article Details
CymaBay Therapeutics to Present at Upcoming Investor Conferences

Added to Collection on: 2021-06-14 12:00:00

Tags for this article:

Life Sciences
Health sciences
Health
Pharmaceutical industry
Biotechnology
Hepatology
Autoimmune diseases
Liver
SVB Leerink
Biopharmaceutical
Forward-looking statement
Primary biliary cholangitis
CymaBay Therapeutics Inc

Click the tags to see associated articles and topics

View Article Details
CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Down Almost -5.63% in 1 Month, But Long Term ...

Added to Collection on: 2021-07-10 18:00:00

Tags for this article:

Financial markets
Stock market
Finance
Financial economics
Equity securities
Corporate finance
Capitalism
Short
Stock
Initial public offering
Share
NASDAQ
CymaBay Therapeutics Inc

Click the tags to see associated articles and topics

View Article Details
Nisa Investment Advisors LLC Purchases 9,320 Shares of CymaBay Therapeutics, Inc ...

Added to Collection on: 2022-04-28 16:36:54

Tags for this article:

Financial economics
Corporate finance
Stock
Stock market
Life Sciences
Finance
CymaBay Therapeutics Inc

Click the tags to see associated articles and topics

View Article Details